Results 91 to 100 of about 47,131 (180)

Piperazine Abuse and Psychosis: A Systematic Review of the Literature

Psychiatry International
Background: Piperazines, synthetic compounds known for their stimulant and hallucinogenic effects, have gained prominence among novel psychoactive substances (NPS) and are frequently associated with adverse psychiatric outcomes, including psychosis ...
Alessio Mosca, Stefania Chiappini, Andrea Miuli, Gianluca Mancusi, Clara Cavallotto, John M. Corkery, Livia Miotti, Mauro Pettorruso, Giovanni Martinotti, Fabrizio Schifano   +9 more
doaj   +1 more source

Reciprocity in global mental health policy [PDF]

, 2014
In an attempt to address inequalities and inequities in mental health provision in low and middle-income countries the WHO commenced the Mental Health Gap Action Programme (mhGAP) in 2008. Four years on from the commencement of this programme of work,
Sashidharan, S.P., White, Ross
core  

Etiology and Management of Sexual Dysfunction [PDF]

, 2009
Sexual dysfunction is the impairment or disruption of any of the three phases of normal sexual functioning, including loss of libido, impairment of physiological arousal and loss, delay or alteration of orgasm.
Bevinahalli Nanjegowda, Raveesh, Muthugaduru Shivarudrappa, Narendra Kumar, Mysore Nagaraj, Anil Kumar, Pai, Nagesh Brahmavar, Rajagopal, Rajendra, Siddika, Nayeema   +5 more
core   +2 more sources

Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study

Pharmaceuticals
Background: Dual disorders (DDs) involve the coexistence of a substance use disorder (SUD) with another mental illness, often from the psychotic and affective categories.
Stefania Chiappini, Clara Cavallotto, Alessio Mosca, Francesco Di Carlo, Tommaso Piro, Giulia Giovannetti, Arianna Pasino, Mariachiara Vicinelli, Chiara Lorenzini, Mariapia Di Paolo, Maria Pepe, Marco Di Nicola, Valerio Ricci, Mauro Pettorruso, Giovanni Martinotti   +14 more
doaj   +1 more source

Improving Quality of Care for Patients With Attention-Deficit/Hyperactivity Disorder in an Early Intervention for Psychosis Service

BJPsych Open
Aims Attention-deficit/hyperactivity disorder (ADHD) is frequently associated with other psychiatric conditions, including psychotic disorders. There is evidence for shared genetic susceptibility to both conditions (Hamshere ML, Stergiakouli E, Langley ...
Masab Hanan, Marlene Kelbrick
doaj   +1 more source

Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes

Brain Sciences
Background: Synthetic cannabinoid receptor agonists (SCRAs, commercially known as “Spice”) have become a leading cause of substance-induced psychosis worldwide.
Alessio Mosca, Stefania Chiappini, Andrea Miuli, Clara Cavallotto, Mauro Pettorruso, Giovanni Martinotti, Fabrizio Schifano   +6 more
doaj   +1 more source

SUBSTANCE-INDUCED PSYCHOSIS AND SCHIZOPHRENIA [PDF]

, 2019
Sónia Farinha Silva, Maria Fátima Urzal, Ines Donas Boto   +2 more
openaire   +1 more source

Substance-Induced Psychosis: An Indicator of Development of Primary Psychosis? [PDF]

American Journal of Psychiatry, 2018
openaire   +2 more sources

Substance-Induced Psychosis and Criminal Responsibility

, 2014
Under investigation in this study are accused persons found to have committed criminal acts while in a state of substance-induced psychosis, where intoxication was voluntary. Its objectives were to determine the treatment at law and in practice of individuals in these circumstances, to identify any forensic and legal factors that contribute to ...
openaire   +1 more source

Editor's corner: DSM-5--ready or not, here it comes. [PDF]

, 2013
Schuckit, Marc A
core   +1 more source